These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1800352)

  • 1. D-penicillamine.
    Singh S; Kohli V
    Indian Pediatr; 1991 Jul; 28(7):779-85. PubMed ID: 1800352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract]   [Full Text] [Related]  

  • 3. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 4. [D-penicillamine and collagen].
    Camus JP; Koeger AC
    Ann Biol Clin (Paris); 1986; 44(3):296-9. PubMed ID: 3538948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of liver cirrhosis and its complications].
    Talke H
    Clin Ter; 1979 Apr; 89(1):3-10. PubMed ID: 540475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolytic activity in patients with hepatolenticular degeneration: the effect of penicillamine].
    Babić T; Relja M
    Lijec Vjesn; 1988 Dec; 110(12):420-2. PubMed ID: 3246941
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
    Charlebois G; Cadotte M; Barbeau A
    Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894
    [No Abstract]   [Full Text] [Related]  

  • 9. Education and imaging. Hepatobiliary and pancreatic: hypersensitivity pneumonitis induced by penicillamine.
    Seo JY; Kim SY; Choi WC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):700. PubMed ID: 19368639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of the hepatolenticular degeneration and results of its continuous therapy].
    Brailski C; Kolarski V; Krastev I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):35-42. PubMed ID: 5501424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Wilson's disease. Introduction to current problems (early diagnosis and therapy)].
    Wewalka F
    Wien Z Inn Med; 1967; 48(12):461-5. PubMed ID: 5620586
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
    Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A
    Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565
    [No Abstract]   [Full Text] [Related]  

  • 13. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
    Hayek HW; Schnack H; Widhalm S
    Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
    [No Abstract]   [Full Text] [Related]  

  • 17. [D(-)penicillamine: pharmacology and clinical uses].
    Gattoni A; De Donato MT; Catalano G; Astarita C; Bernabò R; Altucci P
    Clin Ter; 1982 Nov; 103(4):411-44. PubMed ID: 6217944
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
    López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
    Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of sera from patients with hepatolenticular degeneration treated with D-penicillamine on the development of Wilsonian gliopathy in vitro].
    Weinrauder H; Mossakowski MJ; Ganuszkina IV
    Neuropatol Pol; 1986; 24(2):169-81. PubMed ID: 3785687
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dermatological complications during treatment of Wilsons disease with D-penicillamine].
    Rimbaud P; Mirouze J; Mary P; Meynadier J
    Med Chir Dig; 1973; 2(1):3-8. PubMed ID: 4269689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.